Laurel Wealth Advisors (California)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$261K	Hold	1,100	–	–	0.03%	546
2022 Q3	$220K	Buy	+1,100	New	+$220K	0.02%	583
2021 Q4	–	Sell	-1,137	Closed	-$215K	–	764
2021 Q3	$215K	Buy	+1,137	New	+$215K	0.04%	421